文献速递肝病

肝纤维化筛查促进生活方式改变:4796名个体的前瞻性队列研究

Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 Individuals.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-12-27

该前瞻性筛查研究纳入1850名酒精相关肝病(ALD)风险者和2946名代谢功能障碍相关脂肪性肝病(MASLD)风险者,均提供生活方式建议,8%筛查阳性(瞬时弹性成像≥8 kPa)。6个月时ALD过度饮酒从46%降至32%,MASLD患者饮食、运动、体重均有改善;筛查阳性预测6个月和2年戒酒或减少饮酒。

要点

  • 肝纤维化筛查与ALD和MASLD风险人群饮酒、饮食、体重和运动的持续改善相关。
  • 高危饮酒者中,筛查阳性预测6个月戒酒或减少饮酒(OR 2.45,95%CI 1.32-4.57,P=.005)。
  • MASLD参与者6个月时35%改善饮食、22%增加运动、13%体重下降≥5%。

核心结论

  • 肝纤维化筛查与ALD和MASLD风险人群饮酒、饮食、体重和运动的持续改善相关。
  • 这些改变在筛查阳性参与者中最明显,但不限于该组。

研究设计与样本

  • 前瞻性筛查研究,纳入1850名ALD风险者和2946名MASLD风险者。
  • 所有参与者均接受生活方式建议,通过问卷在1周和6个月评估生活方式改变,2年后对亚组复查。
  • 383名(8%)筛查阳性,定义为瞬时弹性成像≥8 kPa。

主要发现

  • 84%的参与者回复了6个月问卷。
  • ALD参与者中,过度饮酒6个月后从46%降至32%。
  • 仅15%报告饮酒增加,筛查阳性与阴性个体间无差异(P=.698)。
  • 高危饮酒者中,筛查阳性预测6个月戒酒或减少饮酒(OR 2.45,95%CI 1.32-4.57,P=.005)。
  • 752名个体亚组中,2年后过度饮酒从52%降至41%,筛查阳性预测2年戒酒或减少饮酒(OR 1.84,95%CI 1.09-3.11,P=.023)。

关键数值与推荐

  • MASLD参与者6个月时35%改善饮食、22%增加运动、13%报告体重下降≥5%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Early detection of liver fibrosis is believed to promote lifestyle changes. We evaluated self-reported changes in alcohol intake, diet, exercise, and weight after participating in a screening study for liver fibrosis. METHODS: We conducted a prospective screening study of individuals at risk of alcohol-related liver disease (ALD) or metabolic dysfunction-associated steatotic liver disease (MASLD). We provided lifestyle advice to all participants and evaluated lifestyle changes by questionnaires after 1 week and 6 months, with re-examination of a subgroup after 2 years. RESULTS: A total of 1850 at risk of ALD and 2946 at risk of MASLD were included, of whom 383 (8%) were screening positive (transient elastography ≥8 kPa). A total of 84% replied to the 6-month questionnaire. In ALD participants, excessive drinking decreased from 46% to 32% after 6 months. Only 15% reported increased drinking, without differences between screening positive and negative individuals (P = .698). In high-risk drinkers, a positive screening test predicted abstinence or decreased alcohol use after 6 months (odds ratio, 2.45; 95% confidence interval, 1.32-4.57; P = .005). After 2 years, excessive drinking decreased from 52% to 41% in a subgroup of 752 individuals and a positive screening test predicted abstinence or decreased alcohol use after 2 years (odds ratio, 1.84; 95% confidence interval, 1.09-3.11, P = .023). MASLD participants showed similar improvements: 35% improved their diet, 22% exercised more, and 13% reported a weight loss ≥5% after 6 months. CONCLUSIONS: Screening for liver fibrosis is associated with sustained improvements in alcohol consumption, diet, weight, and exercise in at-risk ALD and MASLD. The changes are most pronounced in screening positive participants but not limited to this group.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Kjaergaard M, Lindvig KP, Thorhauge KH, et al. Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 Individuals. Clin Gastroenterol Hepatol. 2023. PMID: 38154729. doi:10.1016/j.cgh.2023.12.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。